rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Sep' 16 Jun' 16 Mar' 16 Dec' 15 Sep' 15
Sales 477.74 412.99 401.65 420.03 389.50
Operating profit 168.98 142.99 129.24 149.22 127.55
Interest 0.62 0.88 0.93 1.31 0.93
Gross profit 175.04 150.59 169.92 152.11 149.66
EPS (Rs) 13.67 11.30 15.34 11.68 10.67
Quarterly  results in details
Sep' 16 Jun' 16 Mar' 16 Dec' 15 Sep' 15
Other income 6.68 8.48 41.61 4.20 23.04
Stock adjustment 3.53 -3.04 -18.05 -17.16 -8.11
Raw material 102.80 94.44 101.26 117.34 100.75
Power and fuel - - - - -
Employee expenses 66.63 64.78 63.53 58.47 58.83
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 135.80 113.82 125.67 112.16 110.48
Provisions made - - - - -
Depreciation 13.45 12.43 11.55 11.12 10.31
Taxation 40.64 38.25 22.66 37.65 44.98
Net profit / loss 120.95 99.91 135.71 103.34 94.37
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 17.69 17.69 17.69 17.69 17.69
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - 230.71
Agg.of non promotoholding (%) - - - - 26.22
OPM (%) 35.37 34.62 32.18 35.53 32.75
GPM (%) 36.13 35.73 38.33 35.86 36.28
NPM (%) 24.97 23.71 30.62 24.36 22.88
Close
Add Ajanta Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Ajanta Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close